PF-1806

N/A

Report date: 2024/09/02 16:28:06
NME

Base Information

Drug NamePF-1806
Drug Alias NamePF-1806PF1806
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 2 receptor modulators
TargetsGlucagon-like peptide 2 receptor
Therapy Area/IndicationsShort Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunoForge Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmunoForge Co Ltd
Inactive CompaniesN/A
Active IndicationsShort Bowel Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A